Technical Analysis for MNMD - Mind Medicine (MindMed) Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 8.68 | -2.58% | -0.23 |
MNMD closed down 2.58 percent on Friday, April 19, 2024, on 56 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 2
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Strong but Oversold | Other | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New Downtrend | Bearish | -2.58% | |
| Stochastic Reached Oversold | Weakness | -2.58% | |
| Strong but Oversold | Other | -2.58% | |
| Oversold Stochastic | Weakness | -2.58% | |
| NR7 | Range Contraction | -8.92% | |
| Multiple of Ten Bearish | Other | -8.92% |
| Alert | Time |
|---|---|
| Up 1% | about 18 hours ago |
| Lower Bollinger Band Support | about 19 hours ago |
| Down 5% | about 19 hours ago |
| Down 3% | about 19 hours ago |
| Fell Below Lower Bollinger Band | about 19 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Drug Development Psychoactive Drugs Entheogens Psychedelic Drug N Dimethyltryptamine
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Drug Development Psychoactive Drugs Entheogens Psychedelic Drug N Dimethyltryptamine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.22 |
| 52 Week Low | 2.41 |
| Average Volume | 2,684,260 |
| 200-Day Moving Average | 4.70 |
| 50-Day Moving Average | 7.96 |
| 20-Day Moving Average | 10.02 |
| 10-Day Moving Average | 9.85 |
| Average True Range | 0.94 |
| RSI (14) | 44.75 |
| ADX | 36.28 |
| +DI | 18.23 |
| -DI | 22.47 |
| Chandelier Exit (Long, 3 ATRs) | 9.41 |
| Chandelier Exit (Short, 3 ATRs) | 11.12 |
| Upper Bollinger Bands | 11.49 |
| Lower Bollinger Band | 8.55 |
| Percent B (%b) | 0.04 |
| BandWidth | 29.33 |
| MACD Line | 0.30 |
| MACD Signal Line | 0.65 |
| MACD Histogram | -0.3551 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.72 | ||||
| Resistance 3 (R3) | 9.71 | 9.35 | 9.54 | ||
| Resistance 2 (R2) | 9.35 | 9.09 | 9.36 | 9.48 | |
| Resistance 1 (R1) | 9.02 | 8.93 | 8.84 | 9.03 | 9.43 |
| Pivot Point | 8.66 | 8.66 | 8.58 | 8.67 | 8.66 |
| Support 1 (S1) | 8.33 | 8.40 | 8.15 | 8.34 | 7.93 |
| Support 2 (S2) | 7.97 | 8.24 | 7.98 | 7.88 | |
| Support 3 (S3) | 7.64 | 7.97 | 7.82 | ||
| Support 4 (S4) | 7.65 |
